Bruce F.

Professional background

Initially a published scientist (100+publications, NIH grants/study section member) Ph.D. in Microbiology/Immunology. Attorney in FDA regulatory areas - device, drugs, biologics, biotech,...) for 28 years (retired) with leading law firms, Venture Partner, TVM (retired) and now high net worth investor and participant in start-up biomedical companies as Board member, Management Team and fund raiser. Using the experience of counseling large and mid-size and early stage pharma (traditional, biotech, generic,...), as Board member with several drug, vaccine and medical technologies companies in which I have invested

Fachgebiete

As an Immunologist/microbiologist publishing over 100 publication, I have a good grasp of scientific nuances impacting on biomedical companies, and have used this scientific knowledge in interacting with FDA, Health Canada, EMA, PMDA (Japan) etc. I was on both an NIH study section as a reviewer, then on a NHLI SBIR/STTR review group until 2020. I have spent almost 30 years as a private attorney in the FDA, USDA, EPA,...areas counseling companies developing products - medical/diagnostic devices, traditional/biotech new drugs and generics, biologics, and companies developing biotech products.
As an attorney, I performed FDA due diligence for venture capital groups, and was a consultant/venture Partner to TVM (Muinch/Boston). Retiring from FDA practice I have helped start several biomedical companies, invested in several start-ups, on the Board of several drug, vaccine and medical technologies companies, and been an investor in several early biomedical startups ($10,000-$300,000).